Surviving severe sepsis: early recognition and treatment.

Bibliographic Details
Published in:Critical Care Nurse Vol. 24; pp. 2 - 16
Main Authors: Ahrens T, Tuggle D
Format: case study CEU exam questions statistics tables/charts Journal Article
Published: American Association of Critical-Care Nurses Oct2004 Supplement
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106677534&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106677534
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02795442
        1GD
      jtl: Critical Care Nurse
      issn: 02795442
      maglogo: N
    pubinfo:
      dt: Oct2004 Supplement
      vid: 24
      pid: 2559
      pub: American Association of Critical-Care Nurses
      place: Alisa Veijo, California
    artinfo:
      ui:
        106677534
        106677534
        2004208269
        NLM15510565
        106677534
      ppf: 2
      ppct: 14
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Surviving severe sepsis: early recognition and treatment.
      aug:
        au:
          Ahrens T
          Tuggle D
        affil: Barnes-Jewish Hospital, St Louis, MO
      sug:
        subj:
          Sepsis Diagnosis
          Sepsis Therapy
          Adult
          Aged
          Education, Continuing (Credit)
          Female
          Fluid Resuscitation
          Fluid Therapy
          Inpatients
          Insulin Therapeutic Use
          Male
          Middle Age
          Mortality Prevention and Control
          Multiple Organ Dysfunction Syndrome
          Recombinant Proteins Therapeutic Use
          Respiration, Artificial
          Sepsis Complications
          Sepsis Drug Therapy
          Sepsis Immunology
          Sepsis Mortality
          Sepsis Physiopathology
          Shock Therapy
          Steroids Administration and Dosage
          Vasopressins Therapeutic Use
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      pubtype: Academic Journal
      doctype:
        case study
        CEU
        exam questions
        statistics
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N